mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.07 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.07 |